Acetyl-L-Carnitine
Acetyl-L-Carnitine (ALCAR)
Brain-boosting form of carnitine that crosses the blood-brain barrier, supporting mental energy, focus, and neuroprotection.
Acetyl-L-Carnitine (ALCAR) is an acetylated form of L-carnitine that readily crosses the blood-brain barrier. It supports mitochondrial energy production in the brain, provides acetyl groups for acetylcholine synthesis, and has neuroprotective properties. Research shows benefits for cognitive function, mood, and age-related mental decline.
Mechanisms of Action
Brain Energy Production
Supports mitochondrial function in brain cells
Acetylcholine Support
Provides acetyl groups for neurotransmitter synthesis
Neuroprotection
Protects brain cells from damage
Recommended Dose
500-2000mg
Optimal Timing
- Morning or early afternoon
- With or without food
Can be taken without food
Best Form
ALCAR powder or capsules
Alternatives: ALCAR HCl
Powder is cost-effective for higher doses. Has a slightly sour taste if taken as powder.
Duration
Minimum: 4 weeks
Optimal: 12 weeks
Cycling: Not required
Note: Can be energizing — avoid evening dosing. Can be taken on empty stomach. Often split into 2 doses.
Personalized Dosage Calculator
Get a dosage recommendation tailored to your body weight, age, goals, and health profile.
Set up your health profile for personalized recommendations
Mental Clarity
Clearer thinking and better focus
Improved Memory
Better recall and learning
Mood Support
May improve mood and reduce mental fatigue
Insufficient data; avoid unless medically advised
May be particularly beneficial; start with lower doses
Who Should NOT Take This
- Seizure disorders (may lower seizure threshold)
- Hypothyroidism (may affect thyroid hormone)
Drug Interactions
May reduce thyroid hormone effectiveness
May affect seizure control
May have mild anticoagulant effects — may affect platelet aggregation or vitamin K-dependent clotting factors, altering anticoagulant efficacy
Possible Side Effects
Tip: Take with food; start with lower dose
Tip: Take earlier in day; reduce dose
Tip: Reduce dose
Warnings
- May affect thyroid function — monitor if on thyroid medication
- Can be stimulating — avoid late in day
Alpha-GPC
enhancesBoth support acetylcholine through different mechanisms
Enhanced cognitive function and memory
Alpha Lipoic Acid
complementaryBoth support mitochondrial function
Synergistic energy and neuroprotective effects
CoQ10
complementaryDifferent roles in mitochondrial energy production
Comprehensive mitochondrial support
PQQ
complementaryBoth support mitochondrial function
Multi-target cellular energy support
Top studies from 40+ peer-reviewed papers
Wadman RI et al. • The Cochrane database of systematic reviews (2020)
“Nusinersen improves motor function in SMA type II, based on moderate-certainty evidence.”
Key Findings:
- Nusinersen improves motor function in SMA type II, based on moderate-certainty evidence.
- One trial of TRH did not measure motor function.
- Further research warranted to confirm findings
Rolim LC et al. • The Cochrane database of systematic reviews (2019)
“We are very uncertain whether ALC causes a reduction in pain after 6 to 12 months' treatment in people with DPN, when compared with placebo, as the evidence is sparse and of low certainty.”
Key Findings:
- The risk of bias was high in both trials of different ALC doses and low in the other two trials.No included trial measured the proportion of participants with at least moderate (30%) or substantial (50%) pain relief.
- ALC reduced pain more than placebo, measured on a 0- to 100-mm VAS (MD -9.16, 95% CI -16.76 to -1.57; three studies; 540 participants; P = 0.02; I² = 56%; random-effects; very low-certainty evidence; a higher score indicating more pain).
- The overall certainty of adverse event evidence for the comparison of ALC versus placebo was low.The study comparing ALC with methylcobalamin reported that 34/117 participants (29.1%) experienced adverse events in the ALC group versus 33/115 (28.7%) in the methylcobalamin group (P = 0.95).
Scafuri L et al. • Nutrients (2025)
“However, the evidence is mixed across supplement types, and further research is needed to determine the most effective and safe approaches.”
Key Findings:
- Curcumin studies presented mixed results.
- Silymarin showed potential for hepatoprotective effects.
- Conclusions: These findings highlight the potential of specific dietary supplements to improve various aspects of breast cancer care.
- However, the evidence is mixed across supplement types, and further research is needed to determine the most effective and safe approaches.
Niu C et al. • Reproductive sciences (Thousand Oaks, Calif.) (2025)
“CoQ10 was the most effective intervention measure for improving sperm concentration, and L-carnitine was regarded as the best treatment method for enhancing sperm motility.”
Key Findings:
- L-carnitine, coenzyme Q10 and L-carnitine + acetyl-L-carnitine significantly improved sperm quality parameters compared with placebo.
- CoQ10 induced the highest increase in sperm concentration (SMD 2.98 [95% CI: 1.13 to 7.87]).
- Furthermore, L-Carnitine has the greatest improvement effect on progressive sperm motility (SMD 4.19 [95% CI: 1.60 to 10.95]).
Zhou P et al. • PloS one (2024)
“The rankings of safety and efficacy of the 12 antioxidants vary.”
Key Findings:
- The rankings of safety and efficacy of the 12 antioxidants vary.
- Due to the low methodological quality of the included studies, the probability ranking cannot fully explain the clinical efficacy, and the results need to be interpreted with caution.
- More high-quality studies are still needed to verify our findings.
Study Type Distribution
Goals This Supplement Supports
Related Goals
This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement.